GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

American Films AMFL · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.09

+37.26%

Close of 3 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2021FY2025

Net income

−$119,086

FY2021FY2025

Free cash flow

—

FY2021FY2025

Shareholders' equity

$3.1m

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Revenue——$1.7m——
Gross profit——$1.3m—−$975
Operating income−$93,418−$235,000−$971,000−$1.5m−$178,000
Net income−$119,086−$534,000−$973,000−$605,000−$175,000
Diluted earnings per share-0.00-0.01-0.02-0.01-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assets$6.1m$5.0m$4.9m$3.4m$2.6m
Cash and short-term investments$500$1,260$4,184$215,974$218,580
Total liabilities$3.0m$2.9m$2.3m$1.2m$2.0m
Debt$2.0m$2.0m$1.3m$1.1m$1.2m
Shareholders' equity$3.1m$2.2m$2.6m$2.2m$635,859
Shares outstanding64m64m64m69m51m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations—−$23,264−$885,270−$1.8m−$161,323
Capital spending—−$4——−$9,747
Free cash flow—−$23,268−$885,270−$1.8m−$171,070

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue———−$2,500—$2,500——
Operating income−$13,822−$17,791−$17,791−$40,255−$17,825−$17,364−$17,974−$35,515
Net income−$24,488−$28,081−$27,734−$42,668−$25,617−$25,149−$25,652−$37,591
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$6.1m$6.1m$6.1m$6.1m$6.0m$5.0m$5.0m$5.0m
Cash and short-term investments$566$1,166$1,166$500$750$750$300$1,260
Debt$1.0m$1.0m$1.0m$1.0m$996,500$992,500$976,500$976,500
Shareholders' equity$3.1m$3.1m$3.1m$3.1m$3.1m$2.1m$2.1m$2.2m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-60.6%12.5%26.2%
Net income-41.8%-31.9%29.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-24.1-6.5-1.1-4.4-36.5
Price to sales——0.6——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return72%268%-62%-73%104604%4137%13329%353%6409%723%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.